Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium

Proceedings of the American Thoracic Society

Volumn 1, Issue 3, 2004, Pages 222-230

  Schleimer, Robert P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Allergic bronchopulmonary aspergillosis; Asthma; Chronic obstructive pulmonary disease; Chronic rhinosinusitis

Indexed keywords

GLUCOCORTICOID;

AIRWAY RESISTANCE; ASTHMA; CELL COMMUNICATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DRUG EFFECT; EPITHELIUM CELL; HOSPITALIZATION; HUMAN; IMMUNOLOGY; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; INNATE IMMUNITY; RESPIRATORY SYSTEM; RESPIRATORY TRACT MUCOSA; REVIEW; SENSITIVITY AND SPECIFICITY;

ADMINISTRATION, INHALATION; AIRWAY RESISTANCE; ASTHMA; CELL COMMUNICATION; EPITHELIAL CELLS; GLUCOCORTICOIDS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 26944454482     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.200402-018MS     Document Type: Article

References (117)

1. Demoly P, Chanez P, Pujol JL, Gauthier-Rouviere C, Michel FB, Godard P, Bousquet J. Fos immunoreactivity assessment on human normal and pathological bronchial biopsies. Respir Med 1995;89:329-335.
2. Sampath D, Castro M, Look DC, Holtzman MJ. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma. J Clin Invest 1999;103:1353-1361.
3. Hart L, Lim S, Adcock I, Barnes PJ, Chung KF. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB in asthma.AmJ Respir Crit Care Med 2000;161:224-231.
4. Vignola AM, Chiappara G, Siena L, Brune A, Gagliardo R, Merendino AM, Polla BS, Arrigo AP, Bonsignore G, Bousquet J, et al. Proliferation and activation of bronchial epithelial cells in corticosteroiddependent asthma. J Allergy Clin Immunol 2001;108:738-746.
5. Mullings RE, Wilson SJ, Puddicombe SM, Lordan JL, Bucchieri F, Djukanovic R, Howarth PH, Harper S, Holgate ST, Davies DE. Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001;108:832-838.
6. Nakao A, Sagara H, Setoguchi Y, Okada T, Okumura K, Ogawa H, Fukuda T. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol 2002;110:873-878.
7. Di Stefano A, Caramori G, Oates T, Capelli A, Lusuardi M, Gnemmi I, Loli F, Chung KF,Donner CF, Barnes PJ, et al. Increased expression of nuclear factor-κB in bronchial biopsies from smokers and patients wtih COPD. Eur Respir J 2002;20:556-563.
8. Schleimer RP. Glucocorticosteroids. In: Middleton E, Reed CE, Ellis EF, Adkinson JNF, Yunginger JW, Busse W, editors. Allergy: principles and practice, 6th ed. St. Louis, MO: Mosby; 2003. p. 870-887.
9. Cohn L, Tepper JS, Bottomly K. Cutting edge: IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J Immunol 1998;161:3813-3816.
10. Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and inteferon γ regulate allergic airway inflammation and mucus production. J Exp Med 1999;190:1309-1317.
11. Jahnsen FL, Brandtzaeg P. Antigen presentation and stimulation of the immune system in human airways. Allergy 1999;54:37-49.
12. Kurosawa S, Myers AC, Chen L, Wang S, Ni J, Plitt JR, Heller NM, Bochner BS, Schleimer RP. Expression of the costimulatory molecule B7-H2 (inducible costimulator ligand) by human airway epithelial cells. Am J Respir Cell Mol Biol 2003;28:563-573.
13. Schleimer RP, Sha Q, VanderMeer J, Lane JAP, Kim J. Epithelial responses in airway inflammation and immunity. Clin Exp Allergy Rev (In press)
14. Kim J, Plitt JR, Myers AC, Schleimer RP. Expression of B7 homolog costimulatory molecules in airway epithelial cells. FASEB J 2003;Abstract 30.25.
15. Jahnsen FL, Farstad IN,Aanesen JP, Brandtzaeg P. Phenotypic distribution of T cells in human nasal mucosa differs from that in the gut. Am J Respir Cell Mol Biol 1998;18:392-401.
16. Atsuta J, Sterbinsky SA, Plitt J, Schwiebert LM, Bochner BS, Schleimer RP. Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1. Am J Respir Cell Mol Biol 1997;17:571-582.
17. Propst SM, Denson R, Rothstein E, Estell K, Schwiebert LM. Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation. J Immunol 2000;165:2214-2221.
18. Galy AHM, Spits H. CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1992;149:775-782.
19. Atsuta J, Plitt J, Bochner BS, Schleimer RP. Inhibition of VCAM-1 expression in human bronchial epithelial cells by gluococorticoids. Am J Respir Cell Mol Biol 1999;20:643-650.
20. Sánchez-Segura A, Brieva JA, Rodríguez C. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. J Allergy Clin Immunol 1998;102:953-960.
21. Schwiebert LA, Beck LA, Stellato C, Bickel CA, Bochner BS, Schleimer RP. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. J Allergy Clin Immunol 1996;97:143-152.
22. Schwiebert LM, Stellato C, Schleimer RP. The epithelium as a target of glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med 1996;154:S16-S20.
23. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
24. Zimmerman N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003;111:227-242.
25. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000;173:27-38.
26. Medzhitov R, Janeway C. Innate immunity. N Engl JMed 2000;343:338-343.
27. Ohashi K, Burkart V, Flohé S, Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J Immunol 2000;164:558-561.
28. Kirschning CJ, Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. Curr Top Microbiol Immunol 2002; 270:121-144.
29. Vabulas RM, Wagner H, Schild G. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 2002;270:169-184.
30. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev 2001;1: 135-145.
31. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-376.
32. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680.
33. Imler J-L, Hoffmann JA. Toll signalling: the TIReless quest for specificity. Nat Immunol 2003;4:105-106.
34. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat Immunol 2003;4:161-167.
35. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000;68:7010-7017.
36. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001;167:1609-1617.
37. Song PI, Park Y-M, Abraham T, Harten B, Zivony A, Neparidze N, Armstrong CA, Ansel JC. Human keratinocytes express functional CD14 and Toll-like receptor 4. J Invest Dermatol 2002;119:424-432.
38. Shuto T, Imasato A, Jono H, Sakai A, Xu H, Watanabe T, Rixter DD, Kai H, Andalibi A, Linthicum F, et al. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J Biol Chem 2002;277:17263-17270.
39. Sha Q, Truong-Tran AQ, Plitt JR, Beck LA, Schleimer RP. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004;31:358-364.
40. Lane AP, Plitt J, Sha Q, Bickel CA, Schleimer RP. Toll-like receptors are expressed in sinonasal mucosa. Otolaryngol Head Neck Surg 2003;13:P174.
41. Silverstein R, Johnson DC. Endogenous versus exogenous glucocorticoid responses to experimental bacterial sepsis. J Leukoc Biol 2003;73: 417-427.
42. Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato ACB, Akira S, Li J-D. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae- induced expression of Toll-like receptor 2. J Biol Chem 2002;277: 47444-47450.
43. Homma T, Hashimoto N, Kato A, Yoshikawa M, Saito H, Matsumoto K. Synergistic effects of cytokines and corticosteroid on TLR2 expression in human respiratory epithelial cells [abstract]. J Allergy Clin Immunol 2003;111:S284.
44. Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc Royal Soc London 1922;93:306-317.
45. Travis SM, Conway B-AD, Zabner J, Smith JJ, Anderson NN, Singh PK, Greenberg EP, Welsh MJ. Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol 1999;20:872-879.
46. Cole AM, Dewan P, Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun 1999;67:3267-3275.
47. Ganz T. Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 2002;109:693-697.
48. Kao CY, Chen Y, Zhao YH, Wu R. ORFeome-based search of airway epithelial cell-specific novel human β -defensin genes. Am J Respir Cell Mol Biol 2003;29:71-80.
49. Becker MN, Diamond G, Verghese MW, Randell SH. CD14-dependent lipopolysaccharide-induced β-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000;275:29731-29736.
50. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway B-AD, Greenberg EP, Valore EV, Welsh MJ, Ganz T, et al. Production of β-defensins by human airway epithelia. Proc Natl Acad Sci 1998;95: 14961-14966.
51. Tomita T, Nagase T, Ohga E, Yamaguchi Y, Yoshizumi M, Ouchi Y. Molecular mechanisms underlying human β-defensin-2 gene expression in a human airway cell line (LC2/ad). Respirology 2002;7:305-310.
52. van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res 2002;51:8-15.
53. Ali M, Maniscalco J, Baraniuk JN. Spontaneous release of submucosal gland serious and mucous cell macromolecules from human nasal explants in vivo. Am J Physiol Lung Cell Mol Physiol 1996;270:L595-L600.
54. Roca-Ferrer J, Mullol J, Pérez M, Xaubet A, Molins L, deHaro J, Shelhamer J, Picado C. Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: comparison between human upper and lower airways. J Allergy Clin Immunol 2000;106:1053-1062.
55. Schoonbrood DFM, Out TA, Lutter R. Reimert CM, vanOverveld FJ, Jansen HM. Plasma protein leakage and local secretion of proteins assessed in sputum in asthma and COPD: the effect of inhaled corticosteroids. Clin Chim Acta 1995;240:163-178.
56. Culpitt SV,Maziak W, Loukidis S, Nightingale JA,Matthews JL, Barnes PJ. Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1635-1639.
57. Kamal AM, Corrigan CJ, Tetley TD, Alaghband-Zadeh J, Smith SF. Effect of fluticasone on the elastase: antielastase profile of the normal lung. Eur J Clin Invest 2002;32:713-719.
58. van Wetering S, van der Linden AC, van Sterkenburg MAJA, de Boer WI, Kuijpers ALA, Schalkwijk J, Hiemstra PS. Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 2000;278:L51-L58.
59. Abbinante-Nissen JM, Simpson LG, Leikauf GD. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am J Physiol 1995;268:L601-L606.
60. Wright JR. Pulmonary surfactant: a front line of lung host defense. J Clin Invest 2003;111:1453-1455.
61. Mariencheck W, Crouch E. Modulation of surfactant protein D expression by glucocorticoids in fetal rat lung. Am J Respir Cell Mol Biol 1994;10:419-429.
62. Phelps DS, Floros J. Dexamethasone in vivo raises surfactant protein B mRNA in alveolar and bronchiolar epithelium. Am J Physiol 1991;260:L146-L152.
63. Venkatesh VC, Iannuzzi DM, Ertsey R, Ballard PL. Differential glucocorticoid regulation of the pulmonary hydrophobic surfactant proteins SP-B and SP-C. Am J Respir Cell Mol Biol 1993;8:222-228.
64. Lawson P, Reid KBM. The roles of surfactant proteins A and D in innate immunity. Immunol Rev 2000;173:66-78.
65. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521-554.
66. McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung. J Clin Invest 2002;109: 707-712.
67. Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, Kim KS. McCormack F X. Surfactant proteins A and D inhibit the growth of gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003;111:1589-1602.
68. McIntosh JC, Swyers AH, Fisher JH, Wright JR. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol 1996;15:509-519.
69. Sugahara K, Iyama K, Sano K, Kuroki Y, Akino T, Matsumoto M. Overexpression of surfactant protein SP-A, SP-B, and SP-C mRNA in rat lungs with lipopolysaccharride-induced injury. Lab Invest 1996; 74:209-220.
70. LeVine AM, Whitsett JA, Gwozdz JA, Richardson TR, Fisher JH, Burhans MS, Korfhagen TR. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000; 165:3934-3940.
71. LeVine AM, Bruno MD, Huelsman KM, Ross GF,Whitsett JA,Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997;158:4336-4340.
72. Noah TL, Murphy PC, Alink JJ, Leigh MW, Hull WM, Stahlman MT, Whitsett JA. Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med 2003;168:685-691.
73. Floros J, Phelps DS, Harding HP, Church S, Ware J. Postnatal stimulation of rat surfactant protein A synthesis by dexamethasone. Am J Physiol 1989;257:L137-L143.
74. Hundertmark S, Dill A, Ebert A, Zimmermann B, Kotelevtsev YV, Mullins JJ, Seckl JR. Foetal lung maturation in 11β-hydroxysteroid dehydrogenase Type 1 knockout mice. Horm Metab Res 2002;34:545-549.
75. Schellhase DE, Shannon JM. Effects of maternal dexamethasone on expression of SP-A, SP-B, and SP-C in the fetal rat lung. Am J Respir Cell Mol Biol 1991;4:304-312.
76. Mendelson CR, Chen C, Boggaram V, Zacarias C, Snyder JM. Regulation of the synthesis of the major surfactant apoprotein in fetal rabbit lung tissue. J Biol Chem 1986;261:9938-9943.
77. Whitsett JA, Weaver TE, Clark JC, Sawtell N, Glasser SW, Korfhagen TR, Hull WM. Glucocorticoid enhances surfactant proteolipid Phe and pVal synthesis and RNA in fetal lung. J Biol Chem 1987;262: 15618-15623.
78. Iannuzzi DM, Ertsey R, Ballard PL. Biphasic glucocorticoid regualtin of pulmonary SP-A: characterization of inhibitory process. Am J Physiol 1993;264:L236-L244.
79. Hoover RR, Floros J. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression. Am J Physiol 1999;276: L917-L924.
80. Gonzales LW, Angampalli S, Guttentag SH, Beers MF, Feinstein SI, Matlapudl A, Ballard PL. Maintenance of differentiated function of the surfactant system in human fetal lung type II epithelial cells cultured on plastic. Pediatr Pathol Mol Med 2001;20:387-412.
81. Mouhieddine-Gueddiche OB, Pinteur C, Chailley-Heu B, Barlier-Mur A-M, Clement A, Bourbon JR. Dexamethasone potentiates keratinoocyte growth factor-stimulated SP-A and SP-B gene expression in alveolar epithelial cells. Pediatr Res 2003;53:231-239.
82. Deterding RR, Shimizu H, Fisher JH, Shannon JM. Regulation of surfactant protein D expression by glucocorticoids in vitro and in vivo. Am J Respir Cell Mol Biol 1994;10:30-37.
83. Rust K, Bingle L, Mariencheck W, Persson A, Crouch EC. Characterization of the human surfactant protein D promoter: transcriptional regulation of SP-D gene expression by glucocorticoids. Am J Respir Cell Mol Biol 1996;14:121-130.
84. Dulkerian SJ, Gonzales LW, Ning Y, Ballard PL. Regulation of surfac tant protein D in human fetal lung. Am J Respir Cell Mol Biol 1996;15:781-786.
85. Drickamer K, Dordal MS, Reynolds L. Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. J Biol Chem 1986;261:6878-6887.
86. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001;180:86-99.
87. Koch A, Melbye M, Sorensen P, Homoe P, Madsen HO, Molbak K, Hansen CH, Andersen LH, Hahn GW, Garred P. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001;285:1316-1321.
88. Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW, et al., Oxford Pneumococcal Surveillance Group. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 2002;359:1569-1573.
89. Garred P, Pressler T, Madsen HO, Frederiksen B, Svejgaard A, Hoiby N, Schwartz M, Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999;104:431-437.
90. Yang IA, Seeney SL, Wolter JM, Anders EM, McCormack JG, Tunnicliffe AM, Rabnott GC, Shaw JG, Dent AG, Kim ST, et al. Mannose- binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes Immun 2003;4:269-274.
91. VanderMeer J, Sha Q, Lane A, Schleimer RP. Innate immunity of the sinonasal cavity: expression of mRNA for complement cascade components and Toll-like receptors. Arch Otolaryngol (In press)
92. Arai T, Tabona P, Summerfield JA. Human mannose-binding protein gene is regulated by interleukins, dexamethasone and heat shock. Q J Med 1993;86:575-582.
93. Cole FS, MatthewsWJ, Rossing TH, Gash DJ, Lichtenberg NA, Pennington JE. Complement biosynthesis by human bronchoalveolar macrophages. Clin Immunol Immunopathol 1983;27:153-159.
94. Strunk RC, Eidlen DM, Mason RJ. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988;81:1419-1426.
95. Varsano S, Kaminsky M, Kaiser M, Rashkovsky L. Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line. Thorax 2000;55: 364-369.
96. Walters DM, Breysse PN, Schofield B, Wills-Karp M. Complement factor 3mediates particulate matter-induced airway hyperresponsiveness. Am J Respir Cell Mol Biol 2002;27:413-418.
97. Humbles AA, Lu B, Nilsson CA, Lilly C, Israel E, Fujiwara Y, Gerard NP, Gerard C. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 2000;406:998-1001.
98. van de Graaf EA, Jansen HM, Bakker MM, Alberts C, Eeftinck-Schattenkerk JK, Out TA. ELISA of complement C3a in bronchoalveolar lavage fluid. J Immunol Methods 1992;147:241-247.
99. Teran LM, Campos MG, Begishvilli BT, Schroder J-M, Djukanovic R, Shute JK, Church MK, Holgate ST, Davies DE. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy 1997;27:396-403.
100. Daffern PJ, Pfeifer PH, Ember JA, Hugli TE. C3a is a chemotaxin for human eosinophils but not for neutrophils: I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995;181: 2119-2127.
101. Drouin SM, Kildsgaard J, Haviland J, Zabner J, Jia HP, McCray PB, Tack BF, Wetsel RA. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol 2001;166:2025-2032.
102. Munoz-Cánoves P, Tack BF, Vik DP. Analysis of complement factor H mRNA expression: dexamethasone and IFN-γ increase the level of H in L cells. Biochemistry 1989;28:9891-9897.
103. Coulpier M, Andreev S, Lemercier C, Dauchel H, Lees O, Fontaine M, Ripoche J. Activation of the endothelium by IL-1α and glucocorticoids results in major increase of complement C3 and factor B production and generation of C3a. Clin Exp Immunol 1995;101:142-149.
104. Friese MA, Hellwage J, Jokiranta TS, Meri S, Muller-Quernheim HJ, Peter HH, Eibel H, Zipfel PF. Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA). Clin Exp Immunol 2000; 121:406-415.
105. Sha Q, Truong-Tran A, Schleimer RP. Differential effects of fluticasone propionate (FP) on gene expression in airway epithelial cells. JAllergy Clin Immunol 2004;113:S51.
106. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000;7:64-69.
107. Steel DM, Donoghue FC, O'Neill RM, Uhlar CM, Whitehead AS. Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines. Scand J Immunol 1996;44:493-500.
108. Cunnane G. Amyloid precursors and amyloidosis in inflammatory arthritis. Curr Opin Rheumatol 2001;13:67-73.
109. Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid A proteins and coronary artery disease. Circulation 1997;96:2914-2919.
110. Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89:381-385.
111. Nel AE, Strachan AF, Welke HE, de Beer FC. Acute phase response in bronchiectasis and bronchus carcinoma. Respiration (Herrlisheim) 1984;45:406-410.
112. Su SB, Gong W, Gao J-L, Shen W, Murphy PM, Oppenheim JJ, Wang JM. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999;189:395-402.
113. He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003;101:1572-1581.
114. Vallon R, Freuler F, Desta-Tsedu N, Robeva A, Dawson J, Wenner P, Engelhardt P, Boes L, Schnyder J, Tschopp C, et al. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol 2001; 166:2801-2807.
115. Liu Y, Cousin JM, Hughes J, Van Damme J, Seckl JR, Haslett C, Dransfield I, Savill J, Rossi AG. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol 1999;162:3639-3646.
116. Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol 2003;178:29-36.
117. Brokaw JJ, White GW, Baluk P, Anderson GP, Umemoto EY, McDonald DM. Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am J Respir Cell Mol Biol 1998;19:598-605.